ΔN133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region

被引:19
作者
Bellini, Ilaria [1 ]
Pitto, Letizia [2 ]
Marini, Maria G. [3 ]
Porcu, Loredana [4 ]
Moi, Paolo [4 ]
Garritano, Sonia [5 ,6 ]
Boldrini, Laura [7 ]
Rainaldi, Giuseppe [2 ]
Fontanini, Gabriella [7 ]
Chiarugi, Massimo [7 ]
Barale, Roberto [1 ]
Gemignani, Federica [1 ]
Landi, Stefano [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56126 Pisa, Italy
[2] CNR, Inst Clin Physiol, Lab Gene & Mol Therapy, I-56100 Pisa, Italy
[3] CNR, Inst Neurogenet & Neurofarmacol, Cagliari, Italy
[4] Univ Cagliari, Dept Biomed Sci & Biotechnol, I-09124 Cagliari, Italy
[5] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy
[6] Natl Inst Canc Res, Genoa, Italy
[7] Univ Pisa, Dept Surg, I-56100 Pisa, Italy
关键词
TP53; Delta N133p53; internal promoter region; IPR; P53; CODON-72; POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; LINES UPDATED COMPILATION; TUMOR-SUPPRESSOR GENE; LUNG-CANCER RISK; COLORECTAL-CANCER; CERVICAL-CANCER; TRANSCRIPTIONAL ACTIVITY; BREAST-CANCER; DNA-REPAIR;
D O I
10.1002/humu.21214
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The transcription of the Delta N133p53 isoform of the TP53 gene is controlled by an internal promoter region (IPR) containing eight polymorphisms in 11 common haplotypes, following a resequencing of 47 Caucasians. We assayed the functional effects of the commonest six haplotypes on the promoter activity with a luciferase reporter system, in HeLa and 293T cells. These studies showed that different IPR haplotypes are associated with differences in the promoter activity resulting in marked variation in the baseline expression of Delta N133p53. In vivo quantitative-polymerase chain reaction (PCR) on human tissues confirmed that the baseline levels of Delta N133p53 showed haplotype specific differences that paralleled those seen in vitro. When cell lines were treated with camptothecin, the fold-increase in Delta N133p53 levels was dose-dependent but haplotype-independent (i.e., similar for all the haplotypes). Finally, we used an electrophoretic mobility shift assay to analyze the rs1794287 polymorphism and found changes in the pattern of protein binding. This partially confirmed our in silico analysis showing that the polymorphism rs1794287 can affect the function of the internal promoter by changing its affinity for several transcription factors. Thus, we showed that the expression of Delta N133p53 is under genetic control, and suggested the presence of interindividual differences underlying this mechanism. Hum Mutat 31: 456-465, 2010. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:456 / 465
页数:10
相关论文
共 74 条
[1]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[2]   A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia [J].
Anensen, Nina ;
Oyan, Anne Margrete ;
Bourdon, Jean-Christophe ;
Kalland, Karl Henning ;
Bruserud, Oystein ;
Gjertsen, Bjorn Tore .
CLINICAL CANCER RESEARCH, 2006, 12 (13) :3985-3992
[3]   Expression of p53 isoforms in squamous cell carcinoma of the head and neck [J].
Boldrup, Linda ;
Bourdon, Jean-Christophe ;
Coates, Philip J. ;
Sjostrom, Bjorn ;
Nylander, Karin .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) :617-623
[4]   p53 and its isoforms in cancer [J].
Bourdon, J-C .
BRITISH JOURNAL OF CANCER, 2007, 97 (03) :277-282
[5]   p53 isoforms can regulate p53 transcriptional activity [J].
Bourdon, JC ;
Fernandes, K ;
Murray-Zmijewski, F ;
Liu, G ;
Diot, A ;
Xirodimas, DP ;
Saville, MK ;
Lane, DP .
GENES & DEVELOPMENT, 2005, 19 (18) :2122-2137
[6]   Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[7]   p53 family isoforms [J].
Bourdon, Jean-Christophe .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2007, 8 (06) :332-336
[8]   p53 genotypes and haplotypes associated with risk of breast cancer [J].
Buyru, Nur ;
Altinisik, Julide ;
Demokan, Semra ;
Dalay, Nejat .
CANCER DETECTION AND PREVENTION, 2007, 31 (03) :207-213
[9]   Matlnspector and beyond: promoter analysis based on transcription factor binding sites [J].
Cartharius, K ;
Frech, K ;
Grote, K ;
Klocke, B ;
Haltmeier, M ;
Klingenhoff, A ;
Frisch, M ;
Bayerlein, M ;
Werner, T .
BIOINFORMATICS, 2005, 21 (13) :2933-2942
[10]  
Cenci M, 2003, ANTICANCER RES, V23, P1385